Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01145456 | Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01317836 | PET-CT in Diagnosis of Pancreatic Cystic Neoplasms | completed | — | 31 | Turku University HospitalOTHER_GOV | 1 | Feb 17, 2014 | clinicaltrials |
| NCT00897741 | Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer | completed | — | 10 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00003434 | Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer | terminated | Phase 1 | 8 | Duke UniversityOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT01097512 | AS703569 and Gemcitabine Combination in Advanced Malignancies | completed | Phase 1 | 66 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 2 | Jan 30, 2014 | clinicaltrials |
| NCT01065870 | Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | unknown | Phase 2 / Phase 3 | 64 | Columbia UniversityOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT02042859 | Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer(EndoHPB) | unknown | Phase 1 | 40 | Ochsner Health SystemOTHER | 0 | Jan 23, 2014 | clinicaltrials |
| NCT00553813 | A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer | terminated | Phase 2 | 23 | Cortice Biosciences, Inc.INDUSTRY | 2 | Jan 22, 2014 | clinicaltrials |
| NCT00636883 | Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer(GEMOX-T) | terminated | Phase 2 | 9 | National Guard Health AffairsOTHER_GOV | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01074996 | Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers(APC-S1) | unknown | Phase 2 | 92 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01941342 | Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy | unknown | Phase 2 | 274 | Southwest Hospital, ChinaOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01096732 | Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)(HIPPoS) | terminated | Phase 2 | 3 | Lisa BaxOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00613730 | Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint(APPRISE 1) | terminated | Phase 2 | 3 | AmgenINDUSTRY | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00551096 | Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors | completed | Phase 1 | 23 | University of Colorado, DenverOTHER | 1 | Dec 25, 2013 | clinicaltrials |
| NCT01789073 | Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay | completed | N/A | 35 | University of CopenhagenOTHER | 1 | Dec 23, 2013 | clinicaltrials |
| NCT00003780 | Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | unknown | Phase 2 | 150 | Meyer PharmaceuticalsINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003797 | Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas | unknown | Phase 2 | 41 | Brown UniversityOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00010270 | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | unknown | Phase 1 | 50 | University Hospital FreiburgOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | completed | Phase 3 | 1,030 | Royal Liverpool University HospitalOTHER_GOV | 13 | Dec 18, 2013 | clinicaltrials |
| NCT00005591 | Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas | withdrawn | Phase 2 | 0 | University of Alabama at BirminghamOTHER | 0 | Dec 13, 2013 | clinicaltrials |
| NCT00900003 | Studying Biomarkers in Patients With Pancreatic Cancer | completed | — | 53 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT01659502 | Investigator's Initiated Phase II Study for Pancreatic Cancer Patients | unknown | Phase 2 | 10 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01994681 | Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air | unknown | — | 100 | Rauscher, Gregory E., M.D. PAINDIV | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00005869 | Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | completed | Phase 3 | 518 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT00003591 | Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer | completed | Phase 2 | 122 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 13, 2013 | clinicaltrials |
| NCT00052689 | Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00085371 | Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01192763 | RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01945879 | Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer | completed | Phase 1 / Phase 2 | 19 | CONKO-StudiengruppeOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT01942629 | Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas | unknown | — | 300 | Rambam Health Care CampusOTHER | 0 | Sep 16, 2013 | clinicaltrials |
| NCT00053222 | Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | completed | Phase 2 | 13 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01931449 | Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy | unknown | Phase 3 | 200 | Southwest Hospital, ChinaOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00425360 | Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | 1,110 | Royal Liverpool University HospitalOTHER_GOV | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00757614 | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | unknown | — | 14,000 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01830322 | Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer | withdrawn | Phase 2 | 0 | Cornerstone PharmaceuticalsINDUSTRY | 1 | Aug 14, 2013 | clinicaltrials |
| NCT00335543 | Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery | completed | Phase 2 | 254 | Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen KrebsgesellschaftOTHER | 3 | Aug 12, 2013 | clinicaltrials |
| NCT00462852 | Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 120 | Hull University Teaching Hospitals NHS TrustOTHER_GOV | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01919151 | Micrometastasis in Gastrointestinal Cancer | unknown | — | 500 | Oslo University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00064051 | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | — | Vion PharmaceuticalsINDUSTRY | 3 | Aug 2, 2013 | clinicaltrials |
| NCT00084383 | Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | completed | Phase 2 | 60 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 22, 2013 | clinicaltrials |
| NCT00002689 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | completed | Phase 2 | 48 | Center for Molecular MedicineOTHER | 1 | Jul 18, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Feb 24, 2014source: clinicaltrials